Stock Details
IQV is IQVIA Holdings Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 210.51$. Average daily volumn in 3 months 1.18M. Market cap 41.11B



Stock symbol : IQV. Exchange : NYSE. Currency : USD
Lastest price : 215.31$. Total volume : 752.91k. Market state PRE
Click reload if you want to check the lastest price on market!!!

IQVIA Holdings Inc. (IQV)
Last Price
215.31$
Change
0.26
Volume
752.91k

Previous Close215.05
Open211.68
Day Range208.28-215.41
Bid168.32 x 1.2k
Ask0.00 x 800
Volume752.91k
Average Volume1.18M
Market Cap41.11B
Beta1.41
52 Week Range194.67-285.61
Trailing P/E39.22
Foward P/E18.51
Dividend (Yield %)N/A
Ex-Dividend DateN/A



Financial Details


According to IQVIA Holdings Inc.'s financial reports the company's revenue in 2021 were 13.87B an increase( +18.18%) over the years 2020 revenue that were of 11.36B. In 2021 the company's total earnings were 966M while total earnings in 2020 were 279M( +246.24%).


Loading ...



Organization

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life scienc... es and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.

Market Cap:
41.11B
Revenue:
13.87B
Total Assets:
24.69B
Total Cash:
1.37B


News about "IQVIA Holdings Inc."

IQVIA Holdings Inc - Stock Financials IQV

Source from : Morningstar%2c Inc. - 2 days ago

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.See details»


iqvia-holdings-inc-nyseiqv-shares-sold-by-ellevest-inc-image

IQVIA Holdings Inc. (NYSE:IQV) Shares Sold by Ellevest Inc.

Source from : Defense World - 4 days ago

Ellevest Inc. cut its position in IQVIA Holdings Inc. (NYSE:IQV โ€“ Get Rating) by 46.4% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission.See details»


zurcher-kantonalbank-zurich-cantonalbank-boosts-holdings-in-iqvia-holdings-inc-nyseiqv-image

Zurcher Kantonalbank Zurich Cantonalbank Boosts Holdings in IQVIA Holdings Inc. (NYSE:IQV)

Source from : Defense World - 1 days ago

Zurcher Kantonalbank Zurich Cantonalbank boosted its position in IQVIA Holdings Inc. (NYSE:IQV โ€“ Get Rating) by 1.1% during the 1st quarter, according to its most recent 13F filing with the Securities ...See details»


IQVIA Holdings Inc. (IQV) Analyst Thoughts: How High Can It Go?

Source from : stocksregister - 4 days ago

IQVIA Holdings Inc. (NYSE:IQV) concluded the trading at $215.05 on Friday, July 01 with a fall of -0.89% from its closing price on previous day. Taking a look at stock we notice that its last check on ...See details»


Ellevest Inc. Trims Stock Position in IQVIA Holdings Inc. (NYSE:IQV)

Source from : ETF Daily News - 4 days ago

Shares of IQVIA stock opened at $215.05 on Friday. IQVIA Holdings Inc. has a fifty-two week low of $194.67 and a fifty-two week high of $285.61. The firm has a market cap of $40.70 billion, a PE ...See details»


IQVIA Holdings Inc. (NYSE:IQV) Stock Holdings Lowered by Spire Wealth Management

Source from : ETF Daily News - 4 days ago

Spire Wealth Management lowered its position in shares of IQVIA Holdings Inc. (NYSE:IQV โ€“ Get Rating) by 61.3% in the 1st quarter, according to its most recent disclosure with the SEC.See details»


IQVIA Holdings Inc - Stock Dividends QTS

Source from : Morningstar%2c Inc. - 5 days ago

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.See details»


Why a Hold Strategy is Apt for IQVIA Holdings (IQV) Stock Now

Source from : Yahoo Finance - 9 days ago

IQVIA Holdings Inc. IQV has an impressive Growth Score of A. This style score condenses all the essential metrics from a companyโ€™s financial statements to get a true sense of the quality and ...See details»


IQVIA Holdings Inc.: Reaffirming BUY and $260 price target

Source from : Yahoo Finance - 20 days ago

IQVIA Holdings is the world's largest provider of biopharmaceutical development services and commercial outsourcing services. Based in Durham, North Carolina, the company was founded in 1982 and ...See details»


IQVIA Appoints Dr. Christina Mack Chief Scientific Officer of Real World Solutions

Source from : Stockhouse - 29 days ago

IQVIA (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and contract services to the life sciences industry, today announced the appointment of Dr. Christina Mack to ...See details»


How The Parts Add Up: XLV Targets $152

Source from : Nasdaq - 8 days ago

Three of XLV's underlying holdings with notable upside to their analyst target prices are Cooper Companies, Inc. (Symbol: COO), Thermo Fisher Scientific Inc (Symbol: TMO), and IQVIA Holdings Inc ...See details»


IROQUOIS CAPITAL NOMINATES SLATE OF HIGHLY QUALIFIED DIRECTOR CANDIDATES FOR ELECTION AT PHARMACYTE'S 2022 ANNUAL MEETING

Source from : MarketWatch - 13 days ago

Prior to joining ZS Associates, he served as a Principal at IQVIA Holdings Inc. ("IQVIA"), a clinical research and health information technology company, from 2018 to 2020, where he served as the ...See details»


Real-world Evidence (RWE) Analytics Market 2022 Size, Share updated Report

Source from : Digital Journal - 5 days ago

Some of the key companies operating in the global RWE analytics market are Clinigen Group plc (U.K.), ICON plc (Ireland), IQVIA Holdings Inc. (U.S.), Oracle Corporation (U.S.), Parexel ...See details»


IQV vs. APP: Which Stock Should Value Investors Buy Now?

Source from : Yahoo Finance - 7 days ago

Investors looking for stocks in the Technology Services sector might want to consider either IQVIA Holdings (IQV) or AppLovin (APP). But which of these two companies is the best option for those ...See details»